SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Starfighters Space Inc

Starfighters Space Inc. (FJET) is experiencing explosive upward momentum following its recent IPO, driven by intense community enthusiasm for the space sector. Traders are actively discussing its significant gains, anticipating further parabolic moves and potential short squeezes, though some express caution regarding its early-stage fundamentals.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum (QBTS) is trending amid analyst upgrades, including a $45 price target from Jefferies, and anticipation for its CES 2026 showcase of commercial quantum computing applications. The community is sharply divided, with bulls highlighting its "quantum supremacy in optimization" and potential as an AI enabler, while bears decry it as a "manipulated pump" detached from fundamental value. This intense debate around its role in the emerging quantum sector is driving significant conversation.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is currently trending due to intense community debate centered on alleged market manipulation, with several major brokers reportedly restricting share purchases. This perceived obstruction, coupled with an unfulfilled share buyback program, is fueling deep investor frustration despite recent significant contract announcements and analyst upgrades highlighting its potential in the AI data center sector. While many bulls see explosive short-squeeze potential from the low float and strong fundamentals, others are losing patience, questioning management's actions and the true impact of its multi-billion pipeline.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

Hycroft Mining Holding Corp

Hycroft Mining is experiencing a surge in conversation following promising drill results from its exploration program, which reported exceptionally high silver grades in the Vortex zone. This news, combined with significant buying activity from a key institutional investor and a generally bullish outlook for precious metals, is fueling widespread community interest. A notable talking point among investors is the recent decision by a former major holder to divest most of its stake in the company, coinciding with its current upward price momentum.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros is trending due to intense anticipation surrounding its imminent FDA decision on Narsoplimab for TA-TMA, with many in the community expecting approval by late December. The recent closing of a significant licensing deal with Novo Nordisk has further bolstered financial stability and fueled investor confidence. This combination of a potentially transformative regulatory event, coupled with substantial short interest, has ignited discussions of a major price movement, though some anticipate continued market manipulation ahead of the binary outcome.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X (CCCX) is trending as excitement builds around its impending merger with Infleqtion, a quantum technology leader. Recent positive analyst coverage, new government contracts, and strategic partnerships, including with NVIDIA, highlight Infleqtion's advanced quantum sensing capabilities and significant revenue pipeline. The community anticipates that the upcoming merger and ticker change to Infleqtion will unlock broader institutional investment and re-rate the stock closer to its quantum peers.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM Integrated Shipping is trending as its board actively reviews multiple acquisition offers, having rejected a management buyout proposal deemed significantly undervalued. Community discussions highlight a strong belief in the company's inherent value and potential for a bidding war, amplified by an ongoing proxy fight where shareholders aim to elect new directors to further maximize value.

First Solar, Inc. is a solar technology company, which engages in the provision of solar modules. It is involved in the design, manufacture, and sale of cadmium tellurid (CdTe) solar modules, which convert sunlight into electricity. The company was founded by Michael J. Ahearn in 1999 and is headquartered in Tempe, AZ.

First Solar Inc

First Solar is trending as Alphabet's acquisition of Intersect Power, a significant customer of its photovoltaic modules, directly links FSLR to the escalating energy demands of AI-driven data centers. The community is actively discussing First Solar's strong position with a vertically integrated U.S. supply chain, touting its potential for government contracts and to meet the surging energy needs for AI infrastructure. Many believe FSLR is well-positioned for continued growth, with analysts raising price targets and speculation focusing on its trajectory to new highs as solar demand for AI infrastructure accelerates.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending following its proposed all-stock merger with fusion energy company TAE Technologies, which initially spurred significant upside volatility. The community remains sharply divided, with bulls anticipating a substantial short squeeze and long-term potential from innovative energy and recent Bitcoin investments, while bears widely dismiss it as a "pump and dump" driven by questionable fundamentals and political discourse. Currently, market participants are debating whether the stock will consolidate for another rally or face further declines, as sentiment remains highly polarized.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is trending as gold surges to new all-time highs, fueled by escalating geopolitical tensions and expectations of future Fed rate cuts. The community is actively debating whether this reflects gold's renewed safe-haven appeal amid global economic uncertainty or signals an overheated, potentially manipulated market. Many anticipate significantly higher prices, while others warn of a potential correction.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mereo BioPharma Group (NASDAQ:MREO) Receives Buy Rating from Needham & Company LLC

Needham & Company LLC restated a "buy" rating and set a $5.00 price objective on shares of Mereo BioPharma Group in a research note on Monday...

Mereo BioPharma Group plc - Sponsored ADR $MREO Shares Bought by Frazier Life Sciences Management L.P.

Frazier Life Sciences Management L.P. lifted its stake in shares of Mereo BioPharma Group plc - Sponsored ADR (NASDAQ:MREO - Free Report) by 20.7% during the second quarter, according to its most...

Mereo BioPharma Group Target of Unusually Large Options Trading (NASDAQ:MREO)

Mereo BioPharma Group plc - Sponsored ADR (NASDAQ:MREO - Get Free Report) saw unusually large options trading on Thursday. Traders purchased 4,694 put options on the stock. This represents an...

Mereo BioPharma Group Target of Unusually High Options Trading (NASDAQ:MREO)

Mereo BioPharma Group plc - Sponsored ADR (NASDAQ:MREO - Get Free Report) was the target of some unusual options trading activity on Wednesday. Stock traders bought 15,681 call options on the stock...

Mereo BioPharma Group plc - Sponsored ADR $MREO Shares Sold by Tema Etfs LLC

Tema Etfs LLC decreased its holdings in shares of Mereo BioPharma Group plc - Sponsored ADR (NASDAQ:MREO - Free Report) by 84.3% in the second quarter, according to its most recent Form 13F filing...

Mereo BioPharma Group plc - Sponsored ADR (NASDAQ:MREO) Receives Consensus Rating of "Moderate Buy" from Brokerages

Mereo BioPharma Group plc - Sponsored ADR (NASDAQ:MREO - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the seven research firms that are covering the stock...

Mereo BioPharma Group (NASDAQ:MREO) Upgraded by Zacks Research to Hold Rating

Zacks Research raised shares of Mereo BioPharma Group from a "strong sell" rating to a "hold" rating in a report on Wednesday...

FY2025 Earnings Forecast for MREO Issued By Leerink Partnrs

Mereo BioPharma Group plc - Sponsored ADR (NASDAQ:MREO - Free Report) - Research analysts at Leerink Partnrs cut their FY2025 earnings per share (EPS) estimates for shares of Mereo BioPharma Group in...

Leerink Partnrs Has Negative Forecast for MREO Q4 Earnings

Mereo BioPharma Group plc - Sponsored ADR (NASDAQ:MREO - Free Report) - Equities research analysts at Leerink Partnrs reduced their Q4 2025 earnings per share (EPS) estimates for shares of Mereo...

Mereo BioPharma Group (NASDAQ:MREO) Releases Quarterly Earnings Results

Mereo BioPharma Group (NASDAQ:MREO - Get Free Report) issued its earnings results on Monday. The company reported ($0.01) EPS for the quarter...

Mereo BioPharma Group Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its portfolio include Etigilimab (MPH-313), Alvelestat (MPH-966), Setrusumab (BPS-804), Navicixizumab (OMP-305B83), Acumapimod (BCT-197), and Leflutrozole (BGS-649). The company was founded by Denise Vera Scots-Knight, Charles Edward Sermon, Alastair Graham MacKinnon, and John P. Richard in March 10, 2015 and is headquartered in London, the United Kingdom.

Current Price	$2.29
Prev Close	$2.00
Open	$2.09
Dividend Yield	0.00%
50-Day Moving Average	$1.95
Beta	1.22
Avg. Volume	1.37M
PE Ratio	-7.59

52-Week High	$3.88
52-Week Low	$1.47
Market Capitalization	$318.19M
EPS (Annual)	-$0.2925
Price to Book	6.83
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

MREO
Mereo Biopharma

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MREO News

MREOMereo Biopharma